Literature DB >> 404155

Blood pressure in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening programme.

T Christensson, K Hellström, B Wengle.   

Abstract

Primary hyperparathyroidism was the most likely diagnosis in sixty-eight non-thiazide treated patients with hypercalcaemia detected in a health screening. The group included fifty-five females and thirteen males with a mean +/- SEM age of 55.0 +/- 0.7 years. On a pair basis, these patients were compared with a series of sixty-eight age- and sex-matched normocalcaemic subjects selected from the health screening register. Five subjects in each group were receiving medication for hypertension. Systolic and diastolic blood pressures were significantly higher in the hypercalcaemic subjects in the remaining fifty-eight pairs (P less than 0.001). This difference was unrelated to impaired renal filtration and many other factors associated with hypertension. It is concluded that hypercalcaemia and/or other effects of deranged parathyroid function per se may result in a blood pressure elevation on which need not necessarily attain the level of hypertension.

Entities:  

Mesh:

Year:  1977        PMID: 404155     DOI: 10.1111/j.1365-2362.1977.tb01581.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

1.  Anesthesia and hyperparathyroidism.

Authors:  Takahiko Okuda; Motoko Oiki; Yasunori Shiokawa; Osamu Kumode; Keita Suekane
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

2.  [Clinical experiences following the surgical therapy of asymptomatic, oligosymptomatic and symptomatic parathyroid gland hyperfunction].

Authors:  B Niederle; R Roka; J Kovarik; K Klaushofer; G Schernthaner; A Fritsch
Journal:  Klin Wochenschr       Date:  1986-10-01

Review 3.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

4.  Effect of chronic elevation of plasma calcium concentration by PTH or vitamin D3 on blood pressure and hypotensive activity of nifedipine in rats.

Authors:  F A Jonkman; M J Thoolen; B Wilffert; A de Jonge; P B Timmermans; P A van Zwieten
Journal:  Pflugers Arch       Date:  1984-12       Impact factor: 3.657

Review 5.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

6.  Parathyroid hypertension.

Authors:  T Christensson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-11

7.  Parathyroid hypertension.

Authors:  A K Sangal; D G Beevers
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

8.  The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.

Authors:  J Levenson; A C Simon; J Bouthier; B C Maarek; M E Safar
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

9.  Parathyroid hormone in coronary artery disease--results of a prospective study.

Authors:  G Herrmann; R Hehrmann; H C Scholz; M Atkinson; P Lichtlen; A von zur Mühlen; R D Hesch
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

Review 10.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.